FDA’s Clinical Trial Inclusion Policy Sold As Mild And Gentle
Bob Temple says encouraging broader populations in clinical trials should not affect study size or enrichment designs.
Bob Temple says encouraging broader populations in clinical trials should not affect study size or enrichment designs.